Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

513
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
513
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

696
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
696
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

121
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
121
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

138
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
138
Causality in Epidemiology01:21

Causality in Epidemiology

765
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
765

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Study on mechanism of serum transitional components of Yinxing Yangnao Formula against vascular dementia based on UPLC- Orbitrap-HRMS combined with network pharmacology].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria.

Drug design, development and therapy·2026
Same author

A preliminary study on the combined assessment of 25-hydroxyvitamin D and thyroid function for predicting diabetic foot risk and amputation in type 2 diabetes.

Frontiers in endocrinology·2026
Same author

IHOG: Interval-Optimized Hamming-Weight-Oriented Grouping for Enhanced Side-Channel Leakage Detection.

Entropy (Basel, Switzerland)·2026
Same author

Palladium-Catalyzed Direct C(sp<sup>3</sup>)-H Arylation and Phenethylation of Toluenes with Aryl Iodides and Styrenes.

The Journal of organic chemistry·2026
Same author

Identification and validation of CNTNAP2/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women.

BMC cancer·2026

Related Experiment Video

Updated: Sep 5, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K

New theoretical ISM-K2 Bayesian network model for evaluating vaccination effectiveness.

Xiaoliang Xie1,2, Bingqi Xie1,3, Dan Xiong4

  • 1School of Mathematics and Statistics, Hunan University of Technology and Busin Ess, Changsha, 410205 China.

Journal of Ambient Intelligence and Humanized Computing
|July 11, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian network model to evaluate vaccination effectiveness (VE) by analyzing vaccine supply chain data. The model enhances VE assessment and vaccine safety monitoring.

Keywords:
Bayesian networkInterpretive structural modelingVaccine effectiveness

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K

Related Experiment Videos

Last Updated: Sep 5, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K

Area of Science:

  • Public Health
  • Epidemiology
  • Health Informatics

Background:

  • Directly obtaining complete Bayesian network (BN) structures via search-scoring algorithms is challenging.
  • Evaluating vaccination effectiveness (VE) requires robust methods integrating expert knowledge and data.

Purpose of the Study:

  • To develop an interpretive structural model with an ISM-K2 algorithm for evaluating VE.
  • To identify risk factors influencing VE throughout the vaccine supply chain.
  • To enhance vaccine safety and post-production supervision.

Main Methods:

  • Utilized expert judgment and historical influenza vaccine data from Hunan Provincial CDC.
  • Employed the ISM-K2 algorithm to construct a Bayesian network model.
  • Developed an evaluation index system for VE.

Main Results:

  • Identified staff quality in vaccine handling as a significant factor impacting VE.
  • Demonstrated the stability, effectiveness, and interpretability of the ISM-K2 BN model for VE assessment.
  • Showcased enhanced post-production vaccine supervision through predictive and diagnostic reasoning.

Conclusions:

  • The ISM-K2 BN model provides a valuable tool for evaluating VE and identifying supply chain vulnerabilities.
  • The study offers a theoretical basis for VE assessment and a scientific method for tracking adverse events.
  • Findings support improving VE and reducing infectious disease transmission.